Cargando…

The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities

Detalles Bibliográficos
Autor principal:	Chandler, Rebecca E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	From the ISoP
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082473/ https://www.ncbi.nlm.nih.gov/pubmed/35532845 http://dx.doi.org/10.1007/s40264-022-01179-y

Ejemplares similares

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
por: Yue, Qun-Ying
Publicado: (2021)

Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
por: Bahri, Priya, et al.
Publicado: (2023)

An Update on the International Society of Pharmacovigilance China Chapter
por: Wen, Yalu, et al.
Publicado: (2022)

How Important is Gender in Leadership in Pharmacovigilance? Personal Reflections from the First Female President of the International Society of Pharmacovigilance
por: Harrison-Woolrych, Mira
Publicado: (2022)

An Update of the North American Chapter of the International Society of Pharmacovigilance (NASoP)
por: Gossell-Williams, Maxine, et al.
Publicado: (2021)

The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic
por: Chandler, Rebecca E, et al.
Publicado: (2020)

A Multidisciplinary Approach in Pharmacovigilance Awareness: ISoP Egypt Chapter’s MedSafetyWeek Experience
por: Rostom, Hadir, et al.
Publicado: (2021)

The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed
por: Younus, Manal M., et al.
Publicado: (2023)

Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature
por: Li, Yanping, et al.
Publicado: (2023)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

The Mathematical and Computational Sciences Special Interest Group of the International Society of Pharmacometrics
por: Moore, Helen
Publicado: (2019)

BioLINK Special Interest Group Session on the Future of Scientific Publishing
por: Markel, Scott
Publicado: (2009)

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
por: Chandler, Rebecca E.
Publicado: (2017)

IMMUNIZATION STRESS-RELATED RESPONSES DURING SKIN TESTING AND CHALLENGE TO COVID-19 VACCINES: A CASE SERIES
por: Jin, H., et al.
Publicado: (2022)

International Society of Pharmacovigilance: COVID-19 role
Publicado: (2020)

Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities
por: Lewis, David John, et al.
Publicado: (2019)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION
por: Rosenblum, J., et al.
Publicado: (2022)

Groupe sanguin ABO et COVID-19
por: Hadj Taieb, Rania, et al.
Publicado: (2021)

The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic
por: Ogar, C., et al.
Publicado: (2020)

Los secretos del certificador de ISO 9000 : una guía para asegurar la certificación de su empresa bajo las normas ISO 9000 y QS 9000 /
por: Taylor, Michel C.
Publicado: (1998)

USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
por: Mohammed, S., et al.
Publicado: (2022)

Challenges in pharmacovigilance
por: Dikshit, R. K.
Publicado: (2010)

Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance
por: Hughes, Richard, et al.
Publicado: (2021)

INTEREST GROUP SESSION—AGING WORKFORCE: WORK AND PRODUCTIVE AGING: OPPORTUNITIES AND CHALLENGES
por: Emerman, Jim, et al.
Publicado: (2019)

Groupe sanguin ABO et sévérité de la COVID-19 : étude monocentrique
por: Dimassi, Imene, et al.
Publicado: (2021)

Réactions cutanées post-vaccin COVID-19
por: Idrissi, Oumayma Kamal, et al.
Publicado: (2021)

TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING
por: Hamel, B., et al.
Publicado: (2022)

Habitudes alimentaires d’un groupe de tunisiens pendant la période de confinement COVID-19
por: Ennaifer, S., et al.
Publicado: (2021)

Érythème noueux post-vaccin anti-COVID-19 : 3 cas
por: Marmech, Cyrine, et al.
Publicado: (2021)

Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
por: Rigamonti, C., et al.
Publicado: (2022)

CHALLENGING OUR ASSUMPTIONS AS WE PLAN FOR ACCESS TO MAJOR CARDIAC PROCEDURES DURING RECOVERY FROM THE COVID-19 PANDEMIC
por: Wu, D, et al.
Publicado: (2021)

Impact de la crise de la COVID-19 sur les internes de dermatologie français
por: Hamann, P., et al.
Publicado: (2020)

Implementing telehealth-delivered group-based education and exercise for osteoarthritis during the COVID-19 pandemic: A mixed-methods evaluation
por: Ezzat, A., et al.
Publicado: (2022)

RISK OF ANAPHYLAXIS TO THE COMPONENTS OF THE COVID-19 VACCINE: A STUDY IN MEXICAN POPULATION
por: Henriquez, R. Lopez, et al.
Publicado: (2022)

Défis de la vaccination contre la COVID-19 en Côte d'Ivoire : connaissances, perception et confiance des populations vis-à-vis des vaccins anti-COVID
por: Agbé, B., et al.
Publicado: (2022)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region
por: Torre, P., et al.
Publicado: (2022)

Zona après vaccination anti-COVID-19 : série descriptive de 10 cas
por: Massip, Edouard, et al.
Publicado: (2021)

COVID-19 : adhésion à la vaccination chez des patients immunodéprimés de dermatologie
por: Lafon, Audrey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5o81is4ve2vg8dn0a4nj73ugu